Back to search
FDAFDA · Food and drugs·Recall number D-106-2013

Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01

Published January 9, 2013 · Recall initiated: October 25, 2012

Summary

FDA records drug Class II recall D-106-2013, published January 9, 2013 and initiated October 25, 2012. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 361,600/1-mL ampules; Lot: Lot 100953A, Exp 01OCT2013; Lot 120803A Exp 01DEC2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulates; may contain glass particles

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot 100953A, Exp 01OCT2013; Lot 120803A Exp 01DEC2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Epinephrine Injection USP, 1 mL, USP 1:1000 (1 mg/mL), SQ/IM, Hospira, Inc., Lake Forest, IL --- NDC 0409-7241-01 recalled?

Yes. FDA published recall D-106-2013 on January 9, 2013. Reported hazard: Presence of Particulates; may contain glass particles

What should I do if I have this product?

Voluntary: Firm initiated · Letter